drugset / Trial / NCT02247505

CKD-397 Drug-drug Interaction Study (B)

NCT02247505

Phase 1 Completed 29 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to investigate to effect of tadalafil on the pharmacokinetic properies of tamsulosin

Timeline

Start
2014-09
Primary completion
2014-10
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Tadalafil Small molecule 5 mg Oral
Subject Tamsulosin Other / unclassified 0.2 mg Oral

Indications

No indication recorded.